Difficulty: Medium
Average Score: 87%
Practice
The most appropriate treatment for newly diagnosed bronchial asthma with occasional symptoms:
Correct answer
B
Rationale
In the management of newly diagnosed bronchial asthma with occasional symptoms, the most appropriate treatment is a low dose inhaled corticosteroid (ICS), which is option B.
The rationale behind this is that ICS is recommended as first-line therapy for asthma due to its anti-inflammatory effects, which help to reduce airway inflammation and prevent symptoms. It is effective in controlling asthma symptoms and reducing the frequency and severity of asthma attacks. Inhaled short-acting B2 agonists (option A) are used for quick relief of acute symptoms but are not recommended as monotherapy for long-term asthma control. Anti-leukotrienes (option C) are typically used as adjunctive therapy for asthma and not as first-line treatment. Slow-release theophylline (option D) is less commonly used now due to its narrow therapeutic window and potential for toxicity.
From an educational perspective, understanding the rationale behind the choice of treatment is crucial for nursing students to provide safe and effective care to pediatric patients with asthma. It is important for students to grasp the principles of asthma management, including the use of ICS as a cornerstone of treatment, to ensure optimal outcomes for their patients. By explaining the reasons why certain options are correct or incorrect, students can develop a deeper understanding of the pharmacological management of asthma and make informed clinical decisions in their practice.
The rationale behind this is that ICS is recommended as first-line therapy for asthma due to its anti-inflammatory effects, which help to reduce airway inflammation and prevent symptoms. It is effective in controlling asthma symptoms and reducing the frequency and severity of asthma attacks. Inhaled short-acting B2 agonists (option A) are used for quick relief of acute symptoms but are not recommended as monotherapy for long-term asthma control. Anti-leukotrienes (option C) are typically used as adjunctive therapy for asthma and not as first-line treatment. Slow-release theophylline (option D) is less commonly used now due to its narrow therapeutic window and potential for toxicity.
From an educational perspective, understanding the rationale behind the choice of treatment is crucial for nursing students to provide safe and effective care to pediatric patients with asthma. It is important for students to grasp the principles of asthma management, including the use of ICS as a cornerstone of treatment, to ensure optimal outcomes for their patients. By explaining the reasons why certain options are correct or incorrect, students can develop a deeper understanding of the pharmacological management of asthma and make informed clinical decisions in their practice.